As of 2025-04-21, the Intrinsic Value of Ortho Clinical Diagnostics Holdings PLC (OCDX) is 22.48 USD. This OCDX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 17.63 USD, the upside of Ortho Clinical Diagnostics Holdings PLC is 27.50%.
The range of the Intrinsic Value is 10.21 - 92.29 USD
Based on its market price of 17.63 USD and our intrinsic valuation, Ortho Clinical Diagnostics Holdings PLC (OCDX) is undervalued by 27.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 10.21 - 92.29 | 22.48 | 27.5% |
| DCF (Growth 10y) | 13.46 - 102.23 | 26.83 | 52.2% |
| DCF (EBITDA 5y) | 24.96 - 33.00 | 28.85 | 63.7% |
| DCF (EBITDA 10y) | 28.00 - 40.21 | 33.63 | 90.8% |
| Fair Value | 1.05 - 1.05 | 1.05 | -94.05% |
| P/E | 2.60 - 3.06 | 2.82 | -84.0% |
| EV/EBITDA | 22.68 - 47.98 | 34.01 | 92.9% |
| EPV | 14.74 - 25.43 | 20.08 | 13.9% |
| DDM - Stable | (0.02) - (0.06) | (0.04) | -100.2% |
| DDM - Multi | 5.40 - 15.91 | 8.10 | -54.1% |
| Market Cap (mil) | 4,191.18 |
| Beta | 0.90 |
| Outstanding shares (mil) | 237.73 |
| Enterprise Value (mil) | 4,191.18 |
| Market risk premium | 4.24% |
| Cost of Equity | 8.70% |
| Cost of Debt | 6.90% |
| WACC | 7.42% |